PSA After Prostatectomy

Prostate cancer recurrence after initial localized treatment, detectable only by a rise in serum prostate-specific antigen (PSA), is a common problem facing clinicians. A rising PSA can cause significant anxiety not only for the patient but also for his physician. Because PSA elevations can precede clinical disease by months or even years, the question of when and if to initiate therapy in these patients can be a dilemma. This article by Neil Baum, MD, uses a case report to lead into a discussion of managing rising PSA after treatment for localized prostate cancer. Since this article was published, there has been new information from the USPSTF about PSA testing. Read about it from our blogger, Alvin Lin, here>>

You might also be interested in these other articles about PSA testing, informed decision-making, and cancer screening from Clinical Geriatrics and Annals of Long-Term Care:

Prostate-Specific Antigen Cancer Screening: Answers to the Critical Questions

Cancer Screening in Older Persons


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s